NU58DP007594
Cooperative Agreement
Overview
Grant Description
Philadelphia Innovative Cardiovascular Health Program - CDC-RFA-DP-23-0005: The Innovative Cardiovascular Health Program Philadelphia Department of Public Health Project Abstract Summary
The Philadelphia Department of Public Health’s Division of Chronic Disease and Injury Prevention (PDPH-CDIP) serves Philadelphia, which has the highest heart disease death rate and second highest cardiovascular disease death rate of any large city in the United States.
Within Philadelphia, there are three census tracts with hypertension crude prevalence rates of 53% or higher which will serve as our target population for this proposal. Each of these census tracts have majority black populations, and their high rates are due in large part to structural racism that has resulted in uneven access to care, neighborhood disinvestment, and other inequitable structures.
Our proposal seeks to improve cardiovascular health and reduce disparities both within the target population and between the target population and Philadelphia at large. We will also place emphasis on achieving high impact and reach across geographic locations where disparate populations can benefit from the program activities.
Through the Innovative Cardiovascular Health Program, PDPH-CDIP will build on partnerships and efforts developed and advanced through the 1422: State and Local Public Health Actions to Prevent Obesity, Diabetes, and Heart Disease and Stroke and DP18-1817: Innovative State and Local Public Health Strategies to Prevent and Manage Diabetes, Heart Disease, and Stroke initiatives to sustain positive long-term outcomes.
CDIP will partner with community and health care-based organizations, including health systems and federally qualified health centers to develop, implement, monitor, and evaluate equity-focused interventions that target the priority population. Through a learning collaborative model, partners will coordinate efforts and exchange ideas to advance health equity and improve health outcomes for communities disproportionately affected by cardiovascular disease in Philadelphia.
The Philadelphia Department of Public Health’s Division of Chronic Disease and Injury Prevention (PDPH-CDIP) serves Philadelphia, which has the highest heart disease death rate and second highest cardiovascular disease death rate of any large city in the United States.
Within Philadelphia, there are three census tracts with hypertension crude prevalence rates of 53% or higher which will serve as our target population for this proposal. Each of these census tracts have majority black populations, and their high rates are due in large part to structural racism that has resulted in uneven access to care, neighborhood disinvestment, and other inequitable structures.
Our proposal seeks to improve cardiovascular health and reduce disparities both within the target population and between the target population and Philadelphia at large. We will also place emphasis on achieving high impact and reach across geographic locations where disparate populations can benefit from the program activities.
Through the Innovative Cardiovascular Health Program, PDPH-CDIP will build on partnerships and efforts developed and advanced through the 1422: State and Local Public Health Actions to Prevent Obesity, Diabetes, and Heart Disease and Stroke and DP18-1817: Innovative State and Local Public Health Strategies to Prevent and Manage Diabetes, Heart Disease, and Stroke initiatives to sustain positive long-term outcomes.
CDIP will partner with community and health care-based organizations, including health systems and federally qualified health centers to develop, implement, monitor, and evaluate equity-focused interventions that target the priority population. Through a learning collaborative model, partners will coordinate efforts and exchange ideas to advance health equity and improve health outcomes for communities disproportionately affected by cardiovascular disease in Philadelphia.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Philadelphia,
Pennsylvania
United States
Geographic Scope
County-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 200% from $1,200,000 to $3,600,000.
City Of Philadelphia was awarded
Philadelphia Cardio Health Program - CDC-RFA-DP-23-0005
Cooperative Agreement NU58DP007594
worth $3,600,000
from National Center for Chronic Disease Prevention and Health Promotion in September 2023 with work to be completed primarily in Pennsylvania United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.945 Assistance Programs for Chronic Disease Prevention and Control.
The Cooperative Agreement was awarded through grant opportunity The Innovative Cardiovascular Health Program.
Status
(Ongoing)
Last Modified 9/26/25
Period of Performance
9/30/23
Start Date
9/29/28
End Date
Funding Split
$3.6M
Federal Obligation
$0.0
Non-Federal Obligation
$3.6M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU58DP007594
Additional Detail
Award ID FAIN
NU58DP007594
SAI Number
NU58DP007594-115345932
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
City Or Township Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CUC0 CDC NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION
Awardee UEI
PSU3TNEFM4N7
Awardee CAGE
4EAA2
Performance District
PA-90
Senators
Robert Casey
John Fetterman
John Fetterman
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Health and Human Services (075-0948) | Health care services | Grants, subsidies, and contributions (41.0) | $1,200,000 | 100% |
Modified: 9/26/25